In Vivo Spectrophotometric Evaluation of Normal, Lesional, and Laser-Treated Skin in Patients with Port-Wine Stains  by Tang, Stephen V. et al.
0022-202X/ 83/ 8005-0420$02.00/0 
THE JOURNAL bF INVESTIGA'I'IVE DERMATOLOGY, 80:420-423, 1983 
Copyrighl © 1983 by The Williams & Wilkins Co. 
Vol. 80, No. 5 
Prinl.ed in U.S.A. 
In Vivo Spectrophotometric Evaluation of Normal, Lesional, and Laser-
Treated Skin in Patients with Port-Wine Stains 
STEPHEN V. TANG, M.D., BARBARA A. GILCHREST, M.D. JoEL M. NoE, M.D., KENNETH A. ARNDT, M.D., 
DONNA B. C. BOURGELAIS, B.S., AND IRVING lTZKAN, PH.D. 
The Laser Unit, Charles A . Dana Research Institute, and the Thorndihe Laborat01y, Beth Israel Hospital: Departm.ent of Dermatology 
(BAG, KAA) and Surge1y (JMN), Harvard Medical School_. Boston; and Avco Everett R esearch Laborato1y, Inc. (DBCB, II), Everett, 
Massachusetts, U.S.A. 
The influence of patient age and argon laser therapy 
on port-wine stains (PWS) was studied quantitatively in 
16 patients aged 15-64 years u sing a spectrophotometer 
and computer graphics/statistics program. Normalized 
reflectance curves revealed a 10-20% decrease with age 
in the reflectance of normal skin from 400 nm to 650 nm, 
with an even more pronounced reflectance decrease in 
the region of peak deoxyhemoglobin absorption at ap-
proximately 555 nm. In each patient, PWS reflectance 
was less than that in the normal skin, as expected, and 
the average discrepancy increased with age from ap-
proximately 25% to 50%, with further reduction at 555 
nm. The data suggest that with advancing age, both 
normal skin and PWS have a greater total hemoglobin 
content and an increased proportion of deoxyhemoglo-
bin, consistent with increasing vascular dilation and 
tortuosity; and that the age-associated changes in PWS 
are an exaggeration of those in normal skin. Laser-
treated PWS in both young and old patients had reflec-
tance curves indistinguishable from those of untreated 
PWS in young patients. This implies, contrary to pub-
lished clinical impressions, that in the absence of scar-
ring the results of argon laser therapy are the same in 
young and old patients, but that only older patients 
experience a significant color shift in the lesion. 
The nevus flammeus is a common congenital lesion mani-
fested primarily in the papillary dermis [1]. In the newborn, it 
is flat , pink to salmon colored, and well circumscribed [2]. A 
small percentage of these capillary malformations continue past 
the first year and evolve slowly with age to an ectatic and 
dilated superficial venous plexus, resulting clinically in a darker, 
more purple, and raised lesion [3]. These nonregressing lesions, 
or port-wine stains (PWS), affect the face or neck in the 
majority of patients and often constitute a major psychosocial 
problem [ 4]. Hypertrophy of involved facial areas and bleeding 
after minor trauma are additional problems for many patients 
with extensive lesions; glaucoma, seizures, and mental retarda-
tion alone or in combination (Sturge-Weber syndrome) can also 
occur in association with PWS [5]. Therapeutic trials with 
cryosurgery, electrocautery, dermabrasion, tattoo with skin 
color pigments, skin grafts, and ionizing radiation all have had 
limited success and/or undesirable side effects [6]. Specifically 
formulated makeup is sometimes helpful, especia lly for macular 
lesions in females, but is less useful for males or for raised 
lesions [5]. 
Argon lasers, which have been used for over 15 years as an 
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optical cautery device to treat retinal detachment (7] , have also 
been applied in the treatment of PWS [8,9]. Theoretically, the 
argon laser is especially well suited to the treatment of cuta-
neous vascular lesions since its major output lines at 488 nm 
and 514 nm (blue-green visible light) are absorbed strongly by 
hemoglobin [10]. Lasers exert their effects on tissue when 
the high-intensity incident beam of photons is absorbed by a 
pigment (chTomophore) with an appropriate absorption spec-
trum, releasing heat at the site of this photo-thermal interaction 
(11]. Hence, the preferential absorption of argon laser energy in 
the skin by intravascular hemoglobin focuses the resultant 
thermal injw-y on the abnormal dermal vasculature, and re-
duces the injury to surrounding cutaneous structures. Indeed, 
treatment of PWS is at present the only medical application for 
the laser which attempts to utilize its wavelength-dependent 
preferential absorption to selectively destroy one anatomic 
target within a complex tissue. 
Early reports of argon laser treatment of PWS noted approx-
imately 71% favorable results, a major advance over other 
modalities, but approximately 12% of patients unpredictably 
experienced hypertrophic scarring o1· an otherwise unwanted 
outcome [12]. Subsequently, it was observed in 62 patients that 
the patient's age, the lesional color, and certain vascular param-
eters measured in histologic sections may be used to predict 
therapeutic response [13]. Statistically, the older patient with 
a dark red or purple lesion and with biopsy-documented ectatic 
and dilated superficial vascular plexus responds to argon laser 
therapy with a greater shift of lesional color toward normal and 
with less risk of hypertrophic scarring than does the younger 
patient with a pink-red lesion and a minimally distorted vas-
cular plexus. Knowledge of these relationships has enabled 
physicians to avoid treating high-risk patients and has led to 
useful modification of argon laser therapy (13,14]. However, a 
small proportion of PWS patients continue to respond unfavor-
ably to the laser even when screened with a lesionaJ biopsy. 
Cutaneous spectrophotometry, a technique that measures 
reflected monochromatic light fi·om skin, can be used as a 
noninvasive method to characterize t he in vivo pigments. We 
have used this technique on the normal, lesional, and laser-
treated skin ofPWS patients to study th e age-related cutaneous 
changes of PWS patients and to develop insight in to the PWS 
lesion, its response to argon laser treatment, and the possibilities 
for alternative treatments. 
MATERIALS AND METHODS 
Patient~ 
Sixteen patients with PWS treated in the Beth Israel Hospital Laser 
Unit were invited to participate in the study. Patients aged 15-64 yeru-s 
were divided in to 3 age groups corresponding to perceived risk catego-
ries [13]: :s 20 yeaJ"s (4 patients, aveJ"age age 16.8 yeru·s), 21-40 years 
(6 patients, average age 20.3 years), and~ 41 years (6 patients, average 
age 52.8 yea1·s) . With one exception, the PWS involved the face or neck, 
with the majority on the cheek and/or forehead. Untreated lesions 
ranged from light pink and macular to daJ"k purple and ra ised, and the 
laseJ" treatment results were in all instances similar to those anticipated 
on clinical grounds [1.3]. 
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Treatment 
A Coherent Radiation Model No. 1000 argon laser was used according 
to described protocols [13,14) at least 3 months before spectrophoto-
metric evaluation. Briefly, consecutive adjacent areas of the PWS were 
treated with a scanning motion tl1l'ough a hand-held fiber optic device 
using a 1 rum-diameter laser beam at a power setting of 1.5-2.0 W and 
a 0.2-s pulse dmation (equivalent to approximately 150-200 W / cm2). 
Spectrophotometry Apparatus and Measurement 
A Carey 17 dual-beam spectrophotometer with fiber-optic conduits 
to a portable rneasmement appliance was used. The incident beam of 
light was at 45° to the skin and illuminated approximately 1 cm2 of 
skin suJTounded by a black chamber (2 x 5 x 3 em) . Reflected light 
was then collected by a fiber-optic conduit oriented normal to the skin 
and automatically compared to an internal reference beam. The resu lt-
ing values were plotted continuously for wavelengths between 400 nm 
(violet-blue) and 650 nm (red). A Kodak white paint standard was used 
to generate the normalizing standard of 100% reflectance for wave-
lengths between 400-650 nm. Reflectance so measured and normalized 
is proportional to 1.00 minus the fraction of incident beam absorbed by 
the test skin. The wavelength range was chosen to include the major 
absorption maxima of oxy- and reduced hemoglobin as well as the 
major output lines of the argon laser (Fig 1) . Normal skin adjacent or 
contralateral to lesional skin was also measured to serve as a contro l. 
All sites studied were representative of the lesional or normal skin. 
Data Analysis 
Values for raw reflectance curves were entered for wavelengths every 
5 nm between 400 nm and 650 nm using a digitizing tablet. Ten 
thousand data points were stored and analyzed using the PROPHET 
timesh:ll'ing system. Patient curves were first normalized by the Kodak 
white (100%) standard. Because the melanin absorption coefficient is 
largest at 400 nm in the wavelength range used, each patient's normal 
skin reflectance at 400 nm was adjusted to the arbitrary value of 0.15. 
All curves for that patient were then vertically adjusted on the loga-
rithmic absorbance scale to compensate for differences in melanin 
among patients. 
These normalized, adjusted curves were analyzed using the 
PROPHET Statistics package and average curves generated for 3 age 
groups (~ 20 years, 21-40 yeaJ's, 2:: 41 years) and age-related changes 
noted. For subsequent statistical analyses, groups were coalesced to 
"young" (~ 20 years) and "old" (;:::: 20 years) and compared using the 
Student t-test. 
RESULTS 
Reflectance values for normal skin of PWS patients show a 
gradual increase from 400 nm (blue-violet) to 650 nm (red) 
consistent with the gradual reduction in melanin absorption 
capacity at longer wavelengths (Figs 1, 2A ). A "double-trough" 
interrupts this trend at the oxyhemoglobin absorption maxima 
542 nm and 577 nm [15] where reflectance is reduced. Normal 
skin of the younger patients is characterized by 10-20% greater 
reflectance throughout the visible spectrum, especially for the 
"red" region of 500-600 nm, than is normal skin of the older 
patients (p < 0.05). In addition, the "double-trough" region of 
the older group is flattened relative to the younger group at the 
intermediate wavelength of approximately 555 nm, suggesting 
greater absorption by deoxyhemoglobin [15] (Figs 1, 2A). 
As expected, in all patients, reflectance of PWS skin was less 
than that of normal skin (p < 0.05). For younger patients, 
however, PWS reflectance cW'ves averaged 25% lower values 
than normal control skin (Fig 2B), while in older patients PWS 
curves averaged 50% lower values (Fig 2C). Moreover, in 
younger patients, the ret1ectance differences between the nor-
mal and PWS skin were greatest between 542-577 nm, the local 
absorption maxima of oxyhemoglobin, and disappeared by 650 
nm; while in older patients, reflectance differences persisted 
throughout the visible spectrum and were greatest at 650 nm. 
The "double-trough" region was flattened in PWS compared to 
normal skin in both age groups, but this change was more 
prominent in older patients. 
Older PWS skin averaged 20-30% lower reflectance than 
younger PWS skin (p < 0.05), consistent with the clinically 
apparent darker purple-red color of these lesions, with further 
separation of the curves for wavelengths > 600 nm (Fig 2D). 
The flattening of the "double-trough" seen in older normal skin 
was even more striking for older PWS skin. Thus, the age-
related changes in PWS skin appear to be an exaggeration of 
similar changes seen in normal skin. 
In both age groups the reflectance CW'ves for the laser-treated 
PWS were statistically identical (p > 0.20) to the reflectance 
cW've of untreated PWS in younger patients for wavelengths 
400-600 nm (Fig 2F), while the r eflectance curve for the treated 
PWS of the older patient, with a darker initial lesion, showed 
a greater shift (p < 0.05) toward his/ her normal skin reflectance 
curve (Fig 2G). 
All reflectance curve differences attributable to the presence 
of the PWS or to patient age were accentuated for wavelengths 
600-650 nm, as compar ed to wavelengths 400-600 nm, i.e. , at 
wavelengths beyond the absorption maxima of oxyhemoglobin 
and beyond the output lines of the argon laser (Fig 2F-G). The 
one exception was the difference between the PWS and normal 
skin of younger patients, in whom curve spearation was maxi-
mal for wavelengths 542-577 nm. 
DISCUSSION 
This study amplifies earlier work [16-19] demonstrating that 
the spectrophotometer provides a rapid, sensit ive, and nonin-
vasive means to quantify alterations in blood or other cutaneous 
chromophores in both normal and lesional skin. Moreover, two 
new concepts emerge from our data. First, differences between 
a patient's PWS and his/her normal skin or between PWS in 
young and old patients are an exaggeration of the age-related 
changes seen in normal skin. These changes are a reduction in 
the reflectance curve over a broad wavelength range consistent 
in part with increased blood content of the skin; and a flattening 
of the "double-trough" region, consistent with a greater admix-
ture of deoxyhemoglobin in the superficial vascular plexus. This 
may reflect increased stagnation of blood due to increased 
vascular tortuosity and dilation both in the abnormal superficial 
plexus of the PWS and in older chronically sun-exposed facial 
skin. This hypothesis is consistent with the histologic findings 
of Barsky et al [3] who studied PWS evolution from childhood 
to late adulthood, and with the common clinical observation of 
telangiectasia of sun-damaged skin. In this hypothesis, the PWS 
vessels would be even more vulnerable t han normal vessels to 
age-associated structural alterations. 
Second, reflectance cm·ves for treated PWS in all age groups 
are identical between 400-600 nm, consistent with the histologic 
studies by Finley et al [20) which showed that the dilated, 
ectatic vascular PWS plexus was replaced after laser treatment 
by a ch:uacteristic network of small-diameter venules regardless 
of patient age, initial lesional color, or therapeutic result. The 
combination of our spectrophotometric data and earlier histo-
logic data strongly suggests that, contrary to current clinical 
impressions, results of argon laser therapy are comparable in 
young and old patients, and that older patients appear to have 
a better result only because the initial PWS is darker and hence 
offers a greater contrast to the treated area. 
Reflectance differences between PWS and normal skin in 
older patients are greatest for wavelengths 600-650 nm. This is 
consistent with the presumed greater proportion of deoxyhem-
oglobin in the PWS, since the absorption coefficient for deox-
yhemoglobin in this region is much greater than that for oxy-
hemoglobin [15] and the lesser absorption by melanin in longer 
wavelengths increases the impact of total hemoglobin absorp-
tion on the reflectance curve beyond 600 nm [11]. Increased 
light scattering by altered connective t issue might also contrib-
ute to the dark purple color (decreased reflectance) of the 
mature PWS. In contrast, in younger patients, maximal curve 
separation occms in the wavelength range 542-577 nm, sug-
gesting that a greater oxyhemoglobin content is t he major 
difference between normal and PWS skin in this age group. 
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FIG 1. Absorpt ion spectra of the ma-
jor human skin pigments. Molar extinc-
tion coefficient for solu tions of oxyhem-
oglobin (IfbO, ), deoxyhemoglobin (lib ), 
and melanin (DOPA-melanin.) a1·e plot-
ted as a function of wavelength in the 
visible light spectrum. The a bsolute 
height of each curve above baseline is 
related to concentration of the solut ion 
measured; relative absorpt ion of the ac-
tual pigments in vivo cannot be deduced. 
Note that melanin absorbs t lu-oughou t 
the spectrum, but absoprt ion is less at 
longer wavelengths. Oxyhemoglobin has 
local absorpt ion maxima at 542 nm and 
577 nm; and deoxyhemoglobin at 555 nm. 
Beyond these local maxima, oxyhemo-
globin falls rapidly to less than 0.5% 
of its local maxima, while deoxyhemoglo-
bin absorption falls more gradua lly to 
approximately 5.0% of its local maxin1a 
[15]. These absorption spectra are mir-
rored in the in vivo cutaneous reflectance 
curves (Fig 2). (Modified and reproduced 
wit h permission from Anderson RR, Par-
rish JA: Optical properties of human 
skin, Photomedicine. Edi ted by JD R e-
gan, JA Parrish. New York, Plenum 
Press, 1982, pp 147-194 .) 
FIG 2. Normalized ri1ean refl ectance 
curves of normal, lesional, and laser-
treated lesional skin. A , Normal skin of 
young and old patients. B, Normal skin 
vs PWS of young patients. C, Normal 
skin vs PWS of old patients. D, P WS of 
young vs old patients. E , Laser-treated 
PWS in young and old patients vs un-
treated PWS in young patients. F , Nor-
mal, PWS, and laser-treated PWS 
in young patients. G, Normal , PWS, 
and laser-treated PWS in old patients . 
Vertical bars at 488 nm and 514 nm 
indicate the major output lines for the 
argon laser. 
The presen t study does not investigat e the spectr opho tome-
ter's po ten t ial usefulness in th e m a nagem ent of individual pa -
t ien ts, although th e desira bility of a n oninvasive, sensit ive, a nd 
specific predictor of a favora ble· PWS r esponse to a rgon laser 
t her a py is clear . U ntil the spectrophotom e ter or other device 
can b e demonstra t ed t o r elia bly predict treatment response, 
physicia ns must con tinue t o ad vise prospective p atients based 
on a va ila ble clinical and his tologic criteria [13]. 
the cha racter of t he PWS and m ay a id in the de velopment of 
future treatment st rategies. 
Recently, developmen t of new technology a nd a pplication of 
adva nced m athem a tical m odeling to the optical properties of 
skin h a ve furth er improved our a bility to qua ntify cuta n eous 
pigm en ts in vivo using noninvasive m ethods [21-24]. Use of 
t h ese sophisticated techniques m ay allow fw-ther insigh t in to 
The authors are grateful to Drs. Bernard Ransil, Seymour Rosen, 
Rober t Stern , and San Wan for helpful discussions and to Carla Burton, 
R.N . and Katherine Russell for their invaluable assistance with om 
patients. Data organization and analysis we1·e perfOl'med on the 
PROPHET system, a national computer resource sponsOl'ed by the 
Division of Resea1·ch Resource, Na tional Insti tutes of Health . 
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Cell Cycle Kinetics of Cultured Human Epidermal Keratinocytes 
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When stratified epithelia maintained in culture are 
used for autoradiographic studies of labeling index, the 
emulsion is usually placed over the uppermost strata of 
the culture. In many cases the distance from the basal 
cell nucleus to the emulsion exceeds the average path-
length of ,8-particle emissions from 14C or 3H. We describe 
a technique for inverting the cultures so that the emul-
sion can be brought into close association with the basal 
cells. 
Attempts to label cultm·ed human epidermal keratin-
ocytes using a pulse of [3H]- or e "C]-thymidine produced 
labeling only at the periphery of the colonies. This was 
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noted when emulsion was laid on top of the colonies but 
also when the emulsion was in close contact with the 
"basal cells" adhering to the plastic culture vessel. Con-
tinuous labeling of the cultures produced nearly 100% 
labeling of all the basal layer, i.e., central and peripheral, 
indicating that the central cells were also in rapid cell 
cycle. The results are interpreted as indicating the pres-
ence of au efficient barrier to free diffusion over the 
center of the colonies, presumably due to the presence 
of several layers of corneocytes. Percent labeled mitoses 
(PLM) studies produced an unusual PLM curve with a 
DMEM: Dulbecco's modified Eagle's medium 
EGF: epidermal growth factor 
HPMA: 2-hydJ·oxylpropyl methacrylate 
LI: label ing index 
Ml: mi totic index 
PLM: percent labeled miio is 
SV40: S imian Virus 40 
T ,: cell cycle duJ·ation 
T,: mi totic duration 
Thd: thymidine 
TK: thy midine kinase 
VCR vincristine sulfate 
